Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by theNormon Jan 14, 2022 2:18pm
251 Views
Post# 34318144

Next news could be DTC eligible for over-night clearance

Next news could be DTC eligible for over-night clearance VPT just got uplisted to OTCQB their premium regulated exchange.
-DTC should follow soon from dept of trade and commerce that is the final step to make VPT available for trading on the big trading apps like RobinHood's  Instituitions can now buy VPT if they like without the DTC BUT retail on apps in U.S.  won't kick in until DTC is achieved within wks at last report.
-This is the Ontario rumour (for now)  George has stated they are in talks with health authourites there recently in a pub cast and in emails to CEO.CA subscribers. This is langford talking to Oh-brother.


@langefjord @Oh-brother it's way, way further along than the so-so written blog suggests. last summer and fall i contacted the tgh head of cardiology about vms tgh already has 4.0 and is currently validating it so possible/probable other centres (the ones in the power-point presentation ie. Edmonton Childrens, Stollery in UK, MD Anderson etc) are also validating 4.0 tech. nrc is onboard to freebie tweak the AI which is already working, and Ontario is fast tracking mass adoption. VMS is quickly to be the new gold standard of care for echocardiology and the major player who is first to acquire it will crush competitors. there's a lot of big players in VPT's corner and the fully automated final product is near term if not ready and just being validated. george is creating the perfect storm for a bidding war


<< Previous
Bullboard Posts
Next >>